Ember Health

What Ember Health does

Ember Health is a for-profit private healthcare services company founded in 2018 and headquartered in Brooklyn, New York. It operates a network of clinics delivering intravenous (IV) ketamine infusions as a treatment for Major Depressive Disorder, the depressive state of Bipolar Disorder, and treatment-resistant depression in adults, adolescents (14+), and older adults (up to 91). The core clinical protocol is a foundational series of four 90-minute infusions over two weeks followed by booster infusions on an as-needed cadence, administered under physician oversight using evidence-based dosing (0.5–1.0 mg/kg over 40 minutes). The company does not operate a software platform; its supporting technology consists of electronic PHQ-9 mood surveys administered every two weeks, online appointment booking, and digital patient records used for outcome tracking and collaborative care reporting to referral providers.

Ember's go-to-market is built on a B2C2B motion anchored by a network of more than 2,000 licensed mental health provider partners (psychiatrists, therapists, primary care providers, nurse practitioners) who refer diagnosed patients into Ember's clinics and participate in shared care planning. Patient acquisition is supported by a free 20-minute consultation call, content marketing, patient storytelling, and employer benefits partnerships with Enthea and First Tracks Health. Ember generates revenue through fee-for-service payments per infusion; pricing is published transparently ($275 orientation visit, $550 per infusion, $2,200 foundation series), with a sliding-scale income-based program for up to 20% of patients and Afterpay installment plans available. There is no in-network insurance coverage for IV ketamine in New York State, but out-of-network plans reimburse approximately 70% of costs, reducing average patient out-of-pocket to about $165 per infusion.

The company maintains five clinic locations across NYC (Brooklyn Heights, Chelsea, Upper East Side, Williamsburg, and Tribeca — the last temporarily closed and slated to reopen in 2026) and operates with 11–50 employees. Ember has accumulated more than 2,500 patients treated and 40,000+ infusions delivered, reports an 84% treatment success rate (including 40% full remission), and maintains clinical research partnerships with Mass General Brigham, UPMC, and NYU Langone Health to publish outcomes data and advance evidence-based standards for IV ketamine care.

Name

Ember Health

Legal name

Ember Health MSO, LCC

Website

https://emberhealth.co

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Ember Health operates a network of clinics in New York City that delivers evidence-based intravenous ketamine infusions to adults, adolescents, and older adults with major depressive disorder and treatment-resistant depression, reimbursed largely through out-of-network insurance and employer benefits partnerships.

Ownership category

akta.pro rank

Product category

Mental Health Services (Ketamine Therapy Clinics)

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

Keywords

• Ketamine infusion therapy
• Treatment-resistant depression
• IV ketamine clinics
• Mental health services
• Depression treatment

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. IV Ketamine Infusion Services: Ember Health generates revenue through fee-for-service payments for in-person IV ketamine infusion treatments. Patients pay per visit at standard rates, with a one-time orientation visit fee and per-infusion charges for foundational and booster treatments. The company also offers a sliding scale income-based pricing program for up to 20% of patients who meet NYC income thresholds and lack out-of-network insurance benefits. Payment plans are available through Afterpay to smooth the cost of the initial foundation series.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Ember Health delivers in-person intravenous (IV) ketamine infusion therapy for adults with Major Depressive Disorder and Treatment-Resistant Depression at five clinic locations across New York City. Treatment is administered as a foundational series of four 90-minute infusions over two weeks, followed by individualized booster infusions approximately every six weeks. Care is delivered by board-certified Emergency Medicine physicians in a 1:1 monitored setting using evidence-based dosing protocols, with bi-weekly PHQ-9 mood tracking and collaborative care coordination with each patient's existing mental health provider.

Product overview

Ember Health is a specialized ketamine clinic network offering intravenous ketamine infusion therapy for depression. The core product is IV ketamine treatment administered at five NYC locations (Brooklyn Heights, Chelsea, Tribeca, Upper East Side, Williamsburg) using evidence-based protocols. The offering consists of a foundational series of four 90-minute infusion appointments over two weeks, followed by individualized booster infusions approximately every six weeks. Supporting services include the Ember Experience (therapeutic environment with rituals of care), Ember Care Model (three-pillar framework of evidence-based, patient-centered, partner-oriented care), Outcomes Tracking via PHQ-9 mood surveys, Insurance Navigation Services, and a Provider Partnership Program. The company also offers specialized treatment programs for various populations including trauma survivors, adolescents, and those with bipolar disorder, all delivered through collaborative care with patients' existing mental health teams.

Differentiator

Problem solved

Functional benefit

Products and services

• IV Ketamine Infusion Treatment for Depression The primary clinical service: intravenous ketamine infusions administered in a monitored medical setting for treatment of Major Depressive Disorder and the depressive state of Bipolar Disorder. Delivered as a foundational series of four 90-minute infusion appointments over two weeks, with booster infusions as symptoms recur. Targeted at adults with treatment-resistant depression who have not achieved adequate relief from traditional antidepressants.
• Specialized Treatment Programs Targeted IV ketamine treatment programs for specific patient populations including suicidal ideation, PTSD and trauma survivors, addiction/substance use, postpartum depression, adolescents (14+), older adults (65+), anxiety, bipolar disorder, and eating disorders, all delivered as adjunctive depression care in collaboration with each patient's existing mental health team.

Quantifiable outcome

• 84% of patients experience meaningful relief from depression (40% full remission, 30% at least 50% reduction in symptoms, 14% noticeable benefits even with smaller score changes)
• +5 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• AfterpayminorOthersAfterpay is a payment plan platform that Ember Health offers to patients to help smooth the cost of the initial foundation series of treatments. This partnership helps patients manage upfront costs while waiting for out-of-network insurance reimbursements or managing irregular income timing.
• EntheacoreGTM or Marketing PartnerEnthea is an employee benefits provider that covers ketamine therapy for employees of participating companies. Ember Health has partnered with Enthea to provide IV ketamine treatment as a covered benefit, potentially offering employees up to full coverage for care at Ember Health.
• First Tracks HealthcoreGTM or Marketing PartnerFirst Tracks Health is an employer benefits provider that covers ketamine therapy for employees of participating companies. Similar to Enthea, this partnership allows employees of partner companies to access IV ketamine treatment at Ember Health as a covered benefit.
• Mass General BrighamcoreStrategic or Co-development PartnerEmber Health has partnered with Mass General Brigham to run research trials, publish outcomes data, and help establish gold standards in the field of IV ketamine for depression treatment.
• UPMCcoreStrategic or Co-development PartnerEmber Health has partnered with UPMC to conduct research trials, publish outcomes data, and advance evidence-based standards for IV ketamine treatment in mental health care.
• NYU Langone HealthcoreStrategic or Co-development PartnerEmber Health has partnered with NYU Langone Health to run research trials, publish outcomes data, and contribute to the establishment of clinical standards for IV ketamine care for depression.
• ReimbursifyminorGTM or Marketing PartnerReimbursify is a technology company that helps patients auto-submit out-of-network insurance claims. Ember Health recommends this third-party service to help patients navigate the notoriously confusing out-of-network reimbursement process, as 30-40% of such claims are denied upon first review.

Scale indicators11 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Mindbloom: Mindbloom is one of the largest ketamine therapy providers in the US, offering at-home and remote-guided ketamine sessions. It is explicitly identified alongside Ember as a peer in the ketamine clinics market and represents the dominant at-home alternative to Ember's in-person IV model.
• Ketamine Clinics Los Angeles: KCLA is a leading IV ketamine infusion clinic operator on the West Coast and is named alongside Ember as a top ketamine clinic brand in the US. Directly comparable specialty outpatient ketamine care model with similar physician-supervised infusion protocols.
• Revitalist Clinic: Revitalist is a publicly-traded ketamine and wellness clinic operator with multiple US locations. It is explicitly identified as a direct competitor alongside Ember and KCLA in the ketamine clinics market, offering similar IV infusion protocols and patient populations.
• Field Trip Health: Field Trip Health operated a network of ketamine-assisted psychotherapy clinics across North America before restructuring. Closely comparable specialty outpatient ketamine care model targeting depression and anxiety with a similar patient experience focus.
• Nue Life: Nue Life is a ketamine therapy provider combining at-home oral ketamine with virtual support and some in-person clinic options. It targets the same treatment-resistant depression population as Ember with a tech-enabled, lower-friction delivery model.
• Actify Neurotherapies: Actify Neurotherapies (formerly ketamine.com) operates a national network of IV ketamine infusion clinics focused on depression, anxiety, PTSD, and chronic pain. Closely comparable specialty outpatient ketamine clinic operator with multi-city US presence.
• Better U (formerly Ketamine Wellness Centers): Better U / Ketamine Wellness Centers operates a network of outpatient IV ketamine clinics across multiple US states. Comparable specialty ketamine clinic model targeting treatment-resistant depression with physician-supervised infusion protocols.

Emerging players

• Compass Pathways: Compass Pathways is a clinical-stage mental health care company developing psilocybin therapy for treatment-resistant depression. Comparable target patient population (TRD) and psychedelic-assisted therapy modality, but distinct molecule and clinical development stage.

Broad incumbents

• Spring Health: Spring Health is a large mental health benefits platform serving employers and payers, covering therapy, coaching, and medication management. Comparable as an employer-sponsored mental health care channel and indirect competitor for ketamine-covered benefits, but broader in scope than Ember's specialty ketamine focus.

Regional players

• Greenleaf Integrative Psychiatry: Regional outpatient psychiatry practice offering IV ketamine infusion therapy as part of a broader mental health service line. Comparable specialty ketamine delivery model but operates in a different US region and offers a wider general psychiatry service menu.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/emberhealth
• Instagraminstagram.com/emberhealth
• Xx.com/ember_health
• Facebookfacebook.com/emberhealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ember Health